BMRN·09061G101·US·equity·Healthcare - Biotechnology-13D/G
BMRN (BIOMARIN PHARMACEUTICAL INC) is held by 209 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), DODGE & COX ($822.6M), PRIMECAP MANAGEMENT CO/CA/ ($801.8M). Net institutional sentiment: Mixed.
See how BMRN's score breaks down across 4 SEC sources
Showing 1-20 of 233
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer